Fandos N, Pérez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M, AIBL Research Group. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst). 2017;8:179-187. Epub 2017 Sep 12 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Automated CSF Tests: Check. Blood Tests: In the Works
  2. Closing in on a Blood Test for Alzheimer’s?
  3. Is Shape of Aβ an Early Blood Biomarker for Alzheimer’s?
  4. Blood Tests for Amyloid Step Out at CTAD